Search Results - "Yondorf, M"
-
1
-
2
-
3
-
4
Temporal Changes in MRI Edema and Resection Cavity Dynamics Subsequent to Implantation of Cesium-131 (Cs-131) Brachytherapy in Patients With Brain Metastases: A Volumetric Analysis From a Prospective Study
Published in International journal of radiation oncology, biology, physics (01-10-2013)Get full text
Journal Article -
5
Dosimetric Comparison of Cs-131 Versus I-125 Intraoperative Brachytherapy for Patients With Resected Brain Metastasis Renders Cs-131 More Sparing of Normal Brain Tissue: Clinical Relevance for Prevention of Radiation Necrosis From a Prospective Trial
Published in International journal of radiation oncology, biology, physics (01-10-2013)Get full text
Journal Article -
6
NTCP Modeling of Hypofractionated Stereotactic Radiation Therapy (HSRT) for Patients With Subtotal Resection (STR) of WHO Grade 1 Meningioma: A Toxicity-Sparing More Convenient Treatment Method
Published in International journal of radiation oncology, biology, physics (01-10-2013)Get full text
Journal Article -
7
-
8
-
9
-
10
NTCP Modeling Proves Dose-Escalation (DE) Hypofractionated Stereotactic Radiation Therapy (HSRT) a Safe Treatment Option for Patients With Subtotal Resection of WHO Grade 2-3 Meningioma
Published in International journal of radiation oncology, biology, physics (01-10-2013)Get full text
Journal Article -
11
-
12
Evaluation of Mini-mental Status Examination Score in a Prospective Study of Neurosurgical Resection and Intraoperative Cesium-131 Radioisotope Brachytherapy in Patients With Newly Diagnosed Brain Metastases
Published in International journal of radiation oncology, biology, physics (01-09-2014)Get full text
Journal Article -
13
-
14
-
15
-
16
SU‐E‐T‐259: Dosimetric Comparison of Cs‐131 Vs. I‐125 Vs. Pd‐103 Intraoperative Brachytherapy in Patients with Resected Brain Metastasis
Published in Medical Physics (01-06-2013)“…Purpose: Cs‐131, I‐125 and Pd‐103, have been used for permanent implant brachytherapy. Cs‐131 has shorter half‐life — 9.7 days as compared to I‐125 and Pd‐103…”
Get full text
Conference Proceeding Journal Article -
17
-
18
-
19
-
20
PO-259 REEXAMINING ABS RECOMMENDATIONS FOR HDR VAGINAL BRACHYTHERAPY FOR UPSC OR CLEAR CELL ENDOMETRIAL CANCER
Published in Radiotherapy and oncology (01-05-2012)Get full text
Journal Article